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ciprofloxacin susceptibilities were epidemiologic markers 
in this study and in previous studies (1,8). The presence of a 
strong β-lactamase with resistance to ampicillin was also a 
marker in this study; epidemic C. jejuni and C. coli isolates 
were β-lactamase negative with susceptibility to ampicillin 
in previous outbreaks in MSM (1,8). Higher proportions of 
C. coli isolates are erythromycin- and multidrug-resistant 
than are C. jejuni isolates (4,6). When indicated, the proper 
antimicrobial treatment of enteric erythromycin- and cip-
rofloxacin-resistant Campylobacter spp. is not known be-
cause no clinical studies have been done for infections with 
such isolates, but tetracycline or amoxicillin/clavulanic 
acid can be used if isolates are susceptible in vitro (1,8; 
this study).
MSM should be counseled about preventing STIs, 
including enteric infections. Barriers should be used dur-
ing genital, oral, and anal sex, and genital and hand wash-
ing before and after sex should be done (9,10). Our study 
increases evidence of clusters of Campylobacter STIs in 
MSM (1,8).
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To the Editor: In an article that reviews evidence of a 
plot to use plague to break the siege of Candia during the 
Venetian–Ottoman War of the 17th century, Dr. Thalassi-
nou and her colleagues (1) identify an incident previously 
unknown to historians of biological warfare. However, the 
authors’ effort to broaden the context for biological weap-
onry is undermined by a reference to an often repeated al-
legation for which no credible evidence exists: namely, that 
during a siege occurring in the Swedish–Russian War of 
1710, the Russians catapulted bodies of plague victims into 
the Swedish-held city of Reval.
Danish historian Karl-Erik Frandsen conducted a 
careful study of the plague outbreak affecting the Baltic 
area during 1709–1713 and found no evidence to sup-
port this allegation (2). Plague was first detected in Re-
val on August 10, 1710, while the army from Russia was 
still approaching the city. Reval was not besieged, and the 
Russians merely camped outside the city while attempt-
ing to isolate it. The army dumped corpses into a stream 
that flowed into Reval, but evidence does not show that 
the dead were plague victims, nor does evidence exist that 
clarifies whether the intent was contamination of the water 
supply or disposal of bodies. Original accounts provide no 
evidence to suggest that Russians hurled bodies into the 
city, much less plague-infected bodies. Frandsen estimates 
that about three quarters of the 20,000 persons in Reval 
died during the outbreak (2).
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Intentional introduction of disease has been rare (3). 
Consequently, the incident identified by Thalassinou and her 
colleagues arouses readers’ interest and inspires speculation.
References
  1. Thalassinou E, Tsiamis C, Poulakou-Rebelakou E, Hatzakis A. 
Biological warfare plan in the 17th century—the siege of  
Candia, 1648–1669. Emerg Infect Dis. 2015;21:2148–53.  
http://dx.doi.org/10.3201/eid2112.130822
  2. Frandsen K-E. The last plague in the Baltic region 1709–1713.  
Copenhagen: Museum Tusculanum Press, University of  
Copenhagen; 2010.
  3. Carus WS. The history of biological weapons use: what we  
know and what we don’t. Health Secur. 2015;13:219–55.  
http://dx.doi.org/10.1089/hs.2014.0092
Address for correspondence: W. Seth Carus, National Defense 
University, Bldg 62, 300 5th Ave SW, Washington, DC 20319, USA; 
email: carus.wmdcenter@gmail.com
Bifidobacterium longum  
Subspecies infantis  
Bacteremia in 3 Extremely 
Preterm Infants  
Receiving Probiotics
Eirin Esaiassen, Pauline Cavanagh, Erik Hjerde, 
Gunnar S. Simonsen, Ragnhild Støen,  
Claus Klingenberg
Author affiliations: University Hospital of North Norway, Tromsø, 
Norway (E. Esaiassen, P. Cavanagh, G.S. Simonsen,  
C. Klingenberg); Arctic University of Norway, Tromsø  
(E. Esaiassen, E. Hjerde, G.S. Simonsen, C. Klingenberg);  
St. Olavs Hospital, Trondheim, Norway (R. Støen); Norwegian 
University of Science and Technology, Trondheim (R. Støen)
DOI: http://dx.doi.org/10.3201/eid2209.160033
To the Editor: Metaanalysis of randomized trials that 
tested different probiotics showed a reduction of ≈50% in 
necrotizing enterocolitis and all-cause deaths in preterm in-
fants (1). Use of probiotics is increasing worldwide (2,3), 
and cases of probiotic sepsis were not reported among 
>5,000 infants in an updated review (1). 
In Norway, a consensus-based protocol recommend-
ing prophylactic probiotic supplementation for preterm in-
fants at highest risk for necrotizing enterocolitis (gestation-
al age <28 weeks, birthweight <1,000 g) was introduced in 
2014. After considering the safety profile, we investigated 
use in preterm infants of a widely used combination of oral 
probiotics (Infloran; Laboratorio Farmacéutico Specialità 
Igienico Terapeutiche, Mede, Italy) that contained 109 Lac-
tobacillus acidophilus (ATCC 4356) and 109 Bifidobacte-
rium longum subspecies infantis (ATCC 15697).
B. longum is a microaerotolerant, anaerobic bacterium 
susceptible to many antimicrobial drugs (Table). This bac-
terium is a rare cause of neonatal infections; until 2015, 
only 2 Bifidobacterium bacteremia cases in premature new-
borns had been reported (4,5).
A total of 290 extremely preterm infants received oral 
probiotics during April 2014–August 2015 in Norway. 
Three patients were given a diagnosis of B. longum bac-
teremia: 2 patients in a neonatal unit in which 17 patients 
were given oral probiotics and 1 patient in a neonatal unit 
in which 31 patients were given oral probiotics (Table).
All 3 infants had respiratory distress syndrome and re-
ceived mechanical ventilation after birth. Enteral feeding 
with human milk was begun on day 1. Oral probiotics (½ 
capsule, 1×/d) were given during the first week of life and 
increased to 1 capsule/day after 4–7 days.
We identified B. longum in blood cultures by using ma-
trix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (Bruker Daltonics, Billerica, MA, USA). 
Whole-genome sequencing (MiSeq, Illumina, San Diego, 
CA, USA) and comparative analysis of nucleotide-level 
variation by using variant cell format in  SAMtools (http://
samtools.sourceforge.net) showed that all 3 blood culture 
isolates and a B. longum strain cultured from an oral probi-
otic capsule were identical.
Patient 1 had sepsis and severe hypotension 8 days af-
ter birth. A blood culture was prepared, and the patient was 
given antimicrobial drugs and vasoactive support. Abdomi-
nal distention, gastric residuals, and feed intolerance de-
veloped the next day, but the patient was cardiorespiratory 
stable. On day 12, abdominal radiographs showed pneu-
moperitoneum. Surgery showed multiple ileal perforations 
and bowel necrosis. Histologic analysis showed classical 
features of necrotizing enterocolitis. The patient received 
an ileostoma and improved after treatment with antimicro-
bial drugs. Blood culture was positive for gram-positive 
rods, which were identified as B. longum. Subsequent clini-
cal course was uneventful.
Patient 2 had apnea, bradycardia, and temperature in-
stability 12 days after birth. A blood culture was prepared, 
and the patient was given antimicrobial drugs. Blood cul-
ture was positive for gram-positive rods, which were iden-
tified as B. longum. Use of oral probiotics was discontin-
ued. The patient recovered rapidly, and subsequent clinical 
course was uneventful.
Patient 3 had sepsis and necrotizing enterocolitis 9 days 
after birth. Ultrasound showed free abdominal fluid. A blood 
culture was prepared, and the patient was given antimicrobi-
al drugs. Surgery showed 2 separate bowel perforations, and 
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